Figure 2From: Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injuryThe effect of ARA290 on inflammation. Early ARA290 treatment reduced mRNA expression of markers of inflammation. IL-6 expression was significantly reduced by early treatment compared to controls (A, p < 0.05), while TNF-α expression showed a comparable tendency (B). The anti-inflammatory effects of late- or repetitive treatment were less pronounced.Back to article page